Rohan Chaubal

Rohan Chaubal has been a member of Linktree for 2 years and joined in January 2024. The social media accounts linked to from Rohan Chaubal are: • LinkedIn • Email • Discord Besides social media accounts, ron128 has populated their site with: • Researchers find key genomic factors causing hormone therapy resistance in breast cancer • Hotspots, resistant tumours behind 40% failure in breast cancer therapy | Hindustan Times Thane - Newspaper - Read this story on Magzter.com • ResearchGate • Web of Science • ORCID • Tata hospital's low-cost intervention: hope to cancer patients • Low-Cost Local Anaesthesia Can Reduce Breast Cancer Recurrence • Game changer in cancer care: Tata hospital to unveil world’s largest nuclear therapeutic facility • Study: 3-month drug therapy for breast cancer sufficient, cheaper - Times of India • Tata hospital's simple intervention gives hope to breast cancer patients • Study on over 1,600 patients suggests simple intervention to increase breast cancer cure rates: Director, Tata Memorial Centre - ET HealthWorld • Immunotherapy: outcomes of ultra low-dose trial offer hope for better global access | Cancerworld Magazine • Tata Memorial’s study suggests simple, low-cost intervention to significantly increase breast cancer cure rate and survival rate • Tata Memorial Centre Offers Quicker, Safer Whole Breast Reconstruction | Mumbai News - Times of India • New hope for breast cancer patients: Indian study identifies key genetic markers for treatment resistance. Why is it significant? • TMC overcomes resistance to hormonal therapy for breast cancer • Dying cancer cells, at times, trigger new tumours, say Tata doctors | Mumbai News - The Times of India • स्तनाच्या कर्करोगावरील प्रतिरोधक जीनोमिकांचा शोध; टाटा मेमोरियल सेंटरचा दावा, भारतीय महिलांमध्ये कर्करोगाचे सर्वाधिक प्रमाण • Deciphering progesterone’s mechanisms of action in breast cancer • x.com • Tata Memorial Centre and National Institute of Biomedical Genomics Uncover Genomic Basis of Hormone Therapy Resistance in Breast Cancer